Be part of the knowledge.™

Oncology and Hematology

873

LikeLikedUnlike

271-280 of 280

HER3-Directed ADCs in Lung Cancer
MinuteCE®
HER3-Directed ADCs in Lung Cancer
- Justin Gainor, MD
  Peer
HER2-Directed ADCs in Gastric Cancer
MinuteCE®
HER2-Directed ADCs in Gastric Cancer
- Jaffer Ajani, MD
  Peer
Nectin-4-Directed ADCs in Bladder Cancer
MinuteCE®
Nectin-4-Directed ADCs in Bladder Cancer
- Gopa Iyer, MD
  Peer
TROP2-Directed ADCs in Bladder Cancer
MinuteCE®
TROP2-Directed ADCs in Bladder Cancer
- Gopa Iyer, MD
  Peer
A Novel Therapeutic Approach in Myeloid Malignancies: Targeting the Neddylation Pathway
CME/CE
A Novel Therapeutic Approach in Myeloid Malignancies: Targeting the Neddylation Pathway
- Jennifer Caudle, DO
  Peer
- Mikkael A. Sekeres, MD, MS
  Peer
- Sara M. Tinsley, PhD, ARNP, AOCNP
  Peer
0.50 credits
Unresectable HCC: An Emerging Era of Combination Therapy – A Clinical Convergence^®
CME/CE
Unresectable HCC: An Emerging Era of Combination Therapy – A Clinical Convergence^®
- Richard S. Finn, MD
  Peer
- Amit Singal, MD, MS
  Peer
- Mark Yarchoan, MD
  Peer
advertisement
Dialogue with the Experts: Best Practices in NSCLC
CME/CE
Dialogue with the Experts: Best Practices in NSCLC
- James "Tate" Thigpen, MD
  Peer
- Kristi Orbaugh, MSN, RNP, AOCN
  Peer
Interview with Makoto Tahara, MD, PhD | Japan
CME/CE
Interview with Makoto Tahara, MD, PhD | Japan
Interview with Joël Guigay, MD, PhD | France
CME/CE
Interview with Joël Guigay, MD, PhD | France
Interview with Jan B. Vermorken, MD, PhD | Belgium
CME/CE
Interview with Jan B. Vermorken, MD, PhD | Belgium
advertisement

Program Chapters

Segment Chapters

Playlist:

Recommended